Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
BioMarin Pharmaceutical Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Features:
• Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
• An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
• Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in San Rafael, California, and employed 1,681 people as of January 21, 2015. The company recorded revenues of $751 million during the financial year ended December 2014 (FY2014), an increase of 36.9% over FY2013. The operating loss of the company was $92.9 million in FY2014, as compared to an operating loss of $156 million in FY2013. The net loss of the company was $134 million in FY2014, as compared to a net loss of $176.4 million in FY2013.
Reasons to Purchase:
• Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
• Track strategic initiatives of the company and latest corporate news and actions
• Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
• Support sales activities by understanding your customers' businesses better
• Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects
Features:
• Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
• An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
• Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in San Rafael, California, and employed 1,681 people as of January 21, 2015. The company recorded revenues of $751 million during the financial year ended December 2014 (FY2014), an increase of 36.9% over FY2013. The operating loss of the company was $92.9 million in FY2014, as compared to an operating loss of $156 million in FY2013. The net loss of the company was $134 million in FY2014, as compared to a net loss of $176.4 million in FY2013.
Reasons to Purchase:
• Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
• Track strategic initiatives of the company and latest corporate news and actions
• Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
• Support sales activities by understanding your customers' businesses better
• Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
